Minnesota · 2025-2026 Regular Session · Bill
SF 4521: Hospital reimbursement for certain biological products to treat rare diseases provisions modifications
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SF 4521 is a bill introduced in the Minnesota Senate on March 17, 2026. According to its official title, it concerns: Hospital reimbursement for certain biological products to treat rare diseases provisions modifications. Primary sponsor: Liz Boldon (Democratic-Farmer-Labor). It lists 1 additional sponsor. Most recent recorded action (March 17, 2026): Referred to Health and Human Services.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic-Farmer-Labor 1 · Republican 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Liz Boldon | Primary sponsor | Democratic-Farmer-Labor | Senate | 25 |
| Julia Coleman | Co-sponsor | Republican | Senate | 48 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Referred to Health and Human Services
- Introduction and first reading